Cheng, X.; Liu, Z.; Cai, J.; Yu, X.; Guo, C.; Liu, W.; Manjili, M.H.; Shah, S.A.; Repasky, E.A.; Subjeck, J.R.;
et al. A Novel Chaperone-Based Cancer Vaccination Enhances Immunotherapeutic Responsiveness Through T Cell Amplification and Tumor Immune Remodeling. Vaccines 2025, 13, 1096.
https://doi.org/10.3390/vaccines13111096
AMA Style
Cheng X, Liu Z, Cai J, Yu X, Guo C, Liu W, Manjili MH, Shah SA, Repasky EA, Subjeck JR,
et al. A Novel Chaperone-Based Cancer Vaccination Enhances Immunotherapeutic Responsiveness Through T Cell Amplification and Tumor Immune Remodeling. Vaccines. 2025; 13(11):1096.
https://doi.org/10.3390/vaccines13111096
Chicago/Turabian Style
Cheng, Xueqian, Zheng Liu, Jinyang Cai, Xiaofei Yu, Chunqing Guo, Wenjie Liu, Masoud H. Manjili, Syed A. Shah, Elizabeth A. Repasky, John R. Subjeck,
and et al. 2025. "A Novel Chaperone-Based Cancer Vaccination Enhances Immunotherapeutic Responsiveness Through T Cell Amplification and Tumor Immune Remodeling" Vaccines 13, no. 11: 1096.
https://doi.org/10.3390/vaccines13111096
APA Style
Cheng, X., Liu, Z., Cai, J., Yu, X., Guo, C., Liu, W., Manjili, M. H., Shah, S. A., Repasky, E. A., Subjeck, J. R., & Wang, X.
(2025). A Novel Chaperone-Based Cancer Vaccination Enhances Immunotherapeutic Responsiveness Through T Cell Amplification and Tumor Immune Remodeling. Vaccines, 13(11), 1096.
https://doi.org/10.3390/vaccines13111096
